STAT3 and cancer: The short-term MTT assay and the long-term colony formation experiment revealed that andrographolide significantly increased doxorubicin-induced cell death in cancer cells, showing that andrographolide increases cancer cell sensitivity to doxorubicin primarily through STAT3 inhibition.